FDA faces major shakeup as CBER chief Peter Marks exits, Trump admin implements cuts across HHS, and new tariff plan creates industry confusion. Sens. Cassidy and Sanders seek answers.
The Trump administration finalized new policies for some Medicare programs on Friday, but left out provisions that would have ...
GSK and Pfizer have settled a lawsuit alleging Pfizer’s RSV shot Abrysvo infringed GSK’s patents. A Pfizer ...
Ousted FDA biologics and vaccine chief Peter Marks was asked to provide non-existent data on the risk from measles vaccines, ...
On the precipice of FDA approval, Novavax's Covid vaccine is now in limbo while a decision to approve or reject it is held up ...
Federal Trade Commission Chairman Andrew Ferguson said he wants to bring back the agency’s case against pharmacy benefit ...
NIH over grant disruptions amid Trump admin cuts, citing canceled grants on DEI/transgender/vaccine topics & mass layoffs of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback